Back
Wayfair Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
40
W
Wayfair
Last Price:
51.19
Seasonality Move:
36.76%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
43.99
Seasonality Move:
10.8%
Sell
40
Wayfair (W)
is a Sell
Is Wayfair a Buy, Sell or Hold?
- The current Wayfair [W] share price is $52.01. The Score for W is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- W is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $44.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
W Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.39 | Sell |
| Relative Strength Index (14 RSI): | 37.36 | Sell |
| Chaikin Money Flow: | 2618995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.99 - 65.37) | Sell |
| Bollinger Bands (100): | (52.5 - 63.08) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.09 | Sell |
| Relative Strength Index (14 RSI): | 43.92 | Sell |
| Chaikin Money Flow: | 101540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.49 - 48.87) | Sell |
| Bollinger Bands (100): | (43.62 - 49.46) | Sell |
W Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.94 | Sell |
| 20-day SMA: | 58.88 | Sell |
| 50-day SMA: | 59.28 | Sell |
| 200-day SMA: | 59.22 | Sell |
| 8-day EMA: | 54.2 | Sell |
| 20-day EMA: | 57.24 | Sell |
| 50-day EMA: | 58.36 | Sell |
| 200-day EMA: | 57.1 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.87 | Buy |
| 20-day SMA: | 46.21 | Sell |
| 50-day SMA: | 47.79 | Sell |
| 200-day SMA: | 42.13 | Buy |
| 8-day EMA: | 44.35 | Sell |
| 20-day EMA: | 45.49 | Sell |
| 50-day EMA: | 46.38 | Sell |
| 200-day EMA: | 44.57 | Sell |
Wayfair Earnings Growth & W Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.44 per share, an increase this year of $2.20 per share, and an increase next year of $1.12 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.
Wayfair Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||